CAVERJECT STERILE POWDER - PWS 11.9MCG/VIAL DIN 02215179
Health Canada record
| Active ingredient(s) | ALPROSTADIL 11.9 MCG |
|---|---|
| Dosage form | Powder For Solution |
| Route | Intracavernosal |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | G04BE01 ALPROSTADIL |
| Original market date | 30-Jul-1996 |
| Current status date | 02-Aug-2006 |
| Source | Health Canada DPD |
Establishment licence of the holder
Pfizer Canada ULC — licence 100255, currently licensed, last inspection rating C (2023-08-07).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing ALPROSTADIL
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02215756 | CAVERJECT STERILE POWDER | PFIZER CANADA ULC | Liquid; Kit; Powder For Solution | ALPROSTADIL 20 MCG | Marketed |
| 02215187 | CAVERJECT STERILE POWDER - PWS 23.2MCG/VIAL | PFIZER CANADA ULC | Powder For Solution | ALPROSTADIL 20 MCG | Marketed |
| 00559253 | PROSTIN VR STERILE SOLUTION | PFIZER CANADA ULC | Solution | ALPROSTADIL 500 MCG | Marketed |
| 02359421 | VITAROS | BGP PHARMA ULC | Cream | ALPROSTADIL 330 MCG | Approved |
| 02359413 | VITAROS | BGP PHARMA ULC | Cream | ALPROSTADIL 220 MCG | Approved |
| 02285282 | ALPROSTADIL INJECTION USP | ADVANCED DOSAGE FORMS INC. | Solution | ALPROSTADIL 500 MCG | Dormant |
| 02241680 | ALPROSTADIL INJECTION, USP | NOVOPHARM LIMITED | Liquid | ALPROSTADIL 500 MCG | Cancelled Post Market |
| 02215748 | CAVERJECT STERILE POWDER - KIT 11.9MCG /VIAL | PFIZER CANADA ULC | Powder For Solution; Liquid; Kit | ALPROSTADIL 11.9 MCG; WATER 99.1 % | Cancelled Post Market |
| 02238595 | MUSE | KNIGHT THERAPEUTICS INC. | Suppository | ALPROSTADIL 1000 MCG | Cancelled Post Market |
| 02238593 | MUSE | KNIGHT THERAPEUTICS INC. | Suppository | ALPROSTADIL 250 MCG | Cancelled Post Market |
| 02238594 | MUSE | KNIGHT THERAPEUTICS INC. | Suppository | ALPROSTADIL 500 MCG | Cancelled Post Market |
| 02238592 | MUSE | PALADIN PHARMA INC. | Suppository | ALPROSTADIL 125 MCG | Cancelled Pre Market |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 266 | 2003-09-16 | New Drug Submission (NDS) | MANUFACTURER NAME CHANGE |
| 812 | 2001-10-12 | New Drug Submission (NDS) | MANUFACTURER NAME CHANGE |
| 6469 | 1996-12-03 | New Drug Submission (NDS) | |
| 6473 | 1996-03-11 | New Drug Submission (NDS) |
International API supply for ALPROSTADIL
2 valid EDQM Certificates of Suitability from 2 holders. 6 active FDA Drug Master Files.
Request a quote for CAVERJECT STERILE POWDER - PWS 11.9MCG/VIAL